[ASAP] Lipid-Conjugated Reduced Haloperidol in Association with Glucose-Based Nanospheres: A Strategy for Glioma Treatment

AI Summary

This article discusses a new strategy for treating glioma using lipid-conjugated reduced haloperidol in combination with glucose-based nanospheres. The research focuses on the potential effectiveness of this approach in treating glioma, a type of brain tumor. The combination of reduced haloperidol and glucose-based nanospheres is being explored as a promising treatment option.

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00468

Leave a Reply